Vun-E TİONG2, Chairil Ariffin AFFİRUL1, Mohamad YUZAİDİ, Imran Alwi RİZAL

Künt Serebrovasküler Yaralanma:Tehlikeli Etkilere Sahip Nadir Bir Olgu

Künt serebrovasküler olaylar (BCVI), çoğu travma kayıtlarında yalnızca % 1'e kadar çıkan nadir bir durumdur. Tarama protokolüyle bile, belgelenen insidans sadece % 2.7'ye kadar çıkabilir. Nadir bir olgu olmasına rağmen, BCVI ile ilişkili komplikasyon riski, özellikle inme için yıkıcı olabilir. Tedavi edilmemiş bir BCVI % 10-40 ölüm riski taşır ve ölümcül olabilir. Genel mortalite % 59 olup, ölümlerin % 80'i BCVI'ye atfedilmiştir. Travmatik boyun yaralanması ile başvuran, daha sonra BCVI tanısı alan bir olguyu sunuyoruz. Bu olguda, tanı ve tedavi tartışılmıştır.

Blunt Cerebrovascular Injury (BCVI): Rare Entity with Dangerous Implications

Blunt cerebrovascular incidents (BCVI) is an uncommon occurrence amountingonly up to 1% in most trauma registries. Even with a screening protocol, thedocumented incidence is just up to 2.7%. Despite a rare occurrence, the riskof complication related to BCVI can be devastating especially stroke. Anuntreated BCVI leads to 10-40% risk of developing stroke which can be fatal.The overall mortality was 59%, and 80% of that death is attributed to BCVI.We report a case who presented with traumatic neck injury subsequentlydiagnosed with BCVI. The presentation, diagnosis and therapy are discussed.

PDF

___

Biffl WL, Ray CE, Moore EE, Franciose RJ, Aly S, Heyrosa MG, Johnson JL, Burch JM. Treatment-related outcomes from blunt cerebrovascular injuries: importance of routine follow-up arteriography. Ann Surg 2002; 235:699-706. discussion 706–7
Berne JD, Norwood SH, McAuley CE, Vallina VL, Creath RG, McLarty J. The High Morbidity of Blunt Cerebrovascular Injury in an Unscreened Population: More Evidence of the Need for Mandatory Screening Protocols. J Am Coll Surg 2001; 192:314-21
Burlew CC, Biffl WL, Moore EE, Barnett CC, Johnson JL, Bensard DD. Blunt cerebrovascular injuries: redefining screening criteria in the era of noninvasive diagnosis. J Trauma Acute Care Surg 2012;72:330-5, discussion 336-7, quiz 539
Cothren CC, Biffl WL, Moore EE, Kashuk JL, Johnson JL. Treatment for blunt cerebrovascular injuries: equivalence of anticoagulation and antiplatelet agents. Arch Surg 2009;144:685-90
Brandon Robert Bruns, Ronald Tesoriero, Joseph Kufera, Clint Sliker, Adriana Laser, Thomas M. Scalea, et al. Blunt cerebrovascular injury screening guideline: what are we willing to miss? Journal of Trauma and Acute Care Surgery. 76:691-5
Fabian TC, Patton JH Jr, Croce MA, Minard G, Kudsk KA, Pritchard FE. Blunt carotid injury: importance of early diagnosis and anticoagulant therapy. Ann Surg. 1996;223: 513- 22; discussion 522-5.
Shaha CP, Croce MA, Fabian TC, Magnotti LJ. Impact of Continous Evaluation of Technology and Therapy: 30 years of Research Reduces Stroke and Mortality from Blunt Cerebrovascular Injury. J Am Coll Surg. 2017;224:595-9
Paulus EM, Fabian TC, Savage SA, Zarzaur BL, Botta V, Dutton W, et al. Blunt cerebrovascular injury screening with 64-channel multidetector computed tomography: more slices finally cut it. J Trauma Acute Care Surg 2014;76:279-85
Biffl WL, Moore EE, Offner PJ, Brega KE, Franciose RJ, Burch JM. Blunt carotid arterial injuries: implications of a new grading scale. J Trauma. 1999;47: 845-53.